Prevalence and risk factors of diabetes in patients with Klinefelter syndrome: a longitudinal observational study
|
|
- Emil Cunningham
- 6 years ago
- Views:
Transcription
1 Prevalence and risk factors of diabetes in patients with Klinefelter syndrome: a longitudinal observational study Mao Jiang-Feng, M.D., a Xu Hong-Li, M.D., a Wu Xue-Yan, M.D., a Nie Min, M.D., a Lu Shuang-Yu, M.D., a Xiang Hong-Ding, M.D., a and Liao Liang-Ming, M.D. b a Key Laboratory of Endocrinology, Department of Endocrinology, Peking Union Medical College Hospital, Ministry of Health, Beijing; and b Institute of Oncology, Fujian University of Traditional Chinese Medicine, Fujian, People's Republic of China Objective: To evaluate the prevalence and risk factors of diabetes in patients with Klinefelter syndrome. Design: Retrospective longitudinal study. Setting: Medical college hospital. Patient(s): Klinefelter group (n ¼ 39) and idiopathic hypogonadotropic hypogonadism (IHH) group (n ¼ 40). Intervention(s): Testosterone replacement therapy. Main Outcome Measure(s): The metabolic parameters, lipid profiles, and sex hormones were compared before and after T replacement therapy. The median duration of follow-up was 4 years in the Klinefelter group and 5.2 years in the IHH group. Result(s): The prevalence of diabetes was 20.5% (8 of 39) in the Klinefelter group and 5% in the IHH group. In the Klinefelter group, the incidence of diabetes was 12.5% in patients with 47,XXY karyotype and 57.1% in patients with other atypical karyotypes, such as 46XY/47XXY chimera. In the Klinefelter group, the average (SD) age at diagnosis of diabetes was years. Four subjects had diabetes before T therapy, and their blood glucose did not improve after T replacement. One patient had a history of acute pancreatitis. Two other subjects had very high triglyceride levels. During the follow-up, body weight increased more in Klinefelter patients than in IHH patients. Conclusion(s): The prevalence of diabetes is higher in Klinefelter patients than in IHH patients, possibly owing to abnormal karyotypes. Other risk factors, such as low T level, high body weight, acute pancreatitis, and high triglyceride levels, may also contribute to the development of diabetes. (Fertil Steril Ò 2012;98: Ó2012 by American Society for Reproductive Medicine.) Key Words: Klinefelter syndrome, diabetes, idiopathic hypogonadotropic hypogonadism, risk factors Discuss: You can discuss this article with its authors and with other ASRM members at fertstertforum.com/maoj-diabetes-klinefelter-syndrome/ Use your smartphone to scan this QR code and connect to the discussion forum for this article now.* * Download a free QR code scanner by searching for QR scanner in your smartphone s app store or app marketplace. Klinefelter syndrome (KS) is a congenital disease caused by additional copies of the X chromosome. It manifests as hypergonadotropic hypogonadism and azoospermia clinically and progressive seminiferous tubule hyaline degeneration pathologically. Klinefelter syndrome is the most common abnormal karyotype diseases, and the incidence in the population is Received December 5, 2011; revised July 19, 2012; accepted July 20, 2012; published online August 30, M.J.-F. has nothing to disclose. X.H.-L. has nothing to disclose. W.X.-Y. has nothing to disclose. N.M. has nothing to disclose. L.S.-Y. has nothing to disclose. X.H.-D. has nothing to disclose. L.L.-M. has nothing to disclose. M.J.-F. and X.H.-L. contributed equally to this work. This study was supported by a grant ( ) from the Natural Science Foundation of China. Reprint requests: Wu Xue-Yan, M.D., Peking Union Medical College Hospital, Department of Endocrinology, Beijing , People's Republic of China ( wsheyan@vip.sina.com). Fertility and Sterility Vol. 98, No. 5, November /$36.00 Copyright 2012 American Society for Reproductive Medicine, Published by Elsevier Inc. 1:500 1,000 (1). The classic karyotype is 47,XXY, whereas other karyotypes, such as 47XXY/46XY chimera, 48XXXY, and 48XXYY, could also be encountered occasionally. Diabetes is significantly more prevalent among KS patients. It has been reported that the incidence of diabetes in KS subjects is 15% 50% and is presumably caused by T deficiency (2 5).Other possible risk factors for diabetes in KS patients have not been fully elucidated. In the present study, a group of KS patients were followed up for a median period of 4 years (range, 1 30 years). VOL. 98 NO. 5 / NOVEMBER
2 ORIGINAL ARTICLE: REPRODUCTIVE ENDOCRINOLOGY Here, we report their sex hormone and metabolic profiles, especially diabetes-related features of these patients, and compare them with patients with idiopathic hypogonadotropic hypogonadism (IHH). MATERIALS AND METHODS Study Population This was a longitudinal, retrospective, and observational study. The retrospective analysis included data from January 1971 to December The observational study contained data generated from January 2003 to December 2011 during the follow-up. Diagnosis of KS included small testes and low T but elevated gonadotropin levels. The diagnosis was confirmed by karyotype analysis from cultured peripheral lymphocytes. Diagnosis of IHH included small testes and low gonadotropin and T levels. The study was approved by the Ethics Committee of Peking Union Medical College Hospital, and written consent was obtained from all patients. Data Collection Comprehensive clinical, physiologic, laboratory, and therapeutic data were retrieved from the database for patients in Beijing Union Hospital. Demographic information included age, sex, body weight, body mass index (BMI), and admission date. Anthroposomatologic parameters, such as lipid profile and fasting blood glucose levels, were compared before and after T replacement therapy (TRT) and between the two groups. The clinical features, comorbidities, and antidiabetic drugs in diabetic KS patients were fully described. The relationship between diabetes and karyotypes was also investigated. Study Definitions Metabolic syndrome was diagnosed according to the International Diabetes Federation 2004 criteria (6). According to the definition, for a man to be defined as having the metabolic syndrome they must have central obesity with waist circumference R90 cm, plus any two of four additional factors. These four factors include triglyceride R1.7 mmol/l, highdensity lipoprotein (HDL)-cholesterol <1.03 mmol/l (or treatment for dyslipidemia), systolic blood pressure R130 mm Hg or diastolic blood pressure R85 mm Hg (or treatment of previous hypertension), and fasting plasma glucose R5.6 mmol/ L (or previously diagnosed type 2 diabetes). Diabetes was diagnosed according to the World Health Organization criteria of Laboratory Measurements Blood samples were taken in a fasting state at 8:00 8:30 AM. Oral glucose tolerance tests (OGTTs) were conducted according to World Health Organization criteria. Briefly, after ingestion of 75 g glucose, serum glucose levels were measured at 0 and 120 minutes. In each patient, total T, total cholesterol, triglyceride, low-density lipoprotein (LDL)-cholesterol, and HDL-cholesterol were measured before and after TRT. Follicle-stimulating hormone, LH, and total T levels were measured using commercial kits by immunoradiometric assay before 2003 and chemiluminescent method (ACS 180 Automatic Chemiluminescence System; Bayer) after The intra- and interassay coefficients of variation of total T were 5.6% and 6.6%, respectively. Statistical Analysis Statistical software (SPSS 11.0) was used for data analysis. Data with normal distribution were expressed as mean SD; data with nonnormal distribution were expressed as medians. The independent t test was used to compare the difference between the Klinefelter group and the IHH group. The pairedsample t test was used to compare the difference before and after TRT. The c 2 test was used to compare the incidence of diabetes in both groups. In subgroup analysis, the c 2 test was also used to compare the incidence of diabetes in different karyotypes. Levels of statistical significance were set at P<.05. RESULTS KS Patients A total of 39 KS patients participated in the study. All patients received TRT and were followed up for a median period of 4 years, ranging from 1 to 30 years. They regularly visited our hospital at an interval of months. The anthroposomatologic parameters, such as gonadotropin levels, sex hormone levels, and lipid profiles before and after T replacement therapy, are listed in Table 1. The regimens of TRT were as follows. Before 1993, 100 mg compound T was injected IM at an interval of 10 days; after 1993, 250 mg T undecanoate was injected IM monthly. During the follow-up, serum T was measured repeatedly, and the interval time of injection was adjusted to keep the serum concentration of T R10 nmol/l. An OGTT was conducted 38 times in the Klinefelter group and 52 times in the IHH group. The OGTT was repeated in some patients during the follow-up if the diagnosis of diabetes could not be made at the first time. Metabolic syndrome. Before TRT, the prevalence of metabolic syndrome was 30.8%. After TRT for a median duration of 4 years the incidence of metabolic syndrome increased to 38.5%. Diabetes. Eight patients were diagnosed with diabetes. The total prevalence of diabetes was 20.5%, higher than in the IHH group (P¼.004). Subgroup analysis showed that the incidence of diabetes was 12.5% in patients with typical karyotype of 47,XXY and 57.1% in patients with other atypical karyotypes, such as 46XY/47XXY chimera (P¼.008). The average (SD) age at diagnosis of diabetes was years (range, years). Four patients presented diabetes before TRT, and the other four patients developed diabetes after TRT was administered. Four patients required insulin. Body weight. During the follow-up, the average body weight dramatically increased, by kg. Among nine patients whose body weight increased by kg (Fig. 1), two developed diabetes VOL. 98 NO. 5 / NOVEMBER 2012
3 Fertility and Sterility TABLE 1 Anthropometry parameters, T levels, and lipid profiles before and after TRT in KS and IHH patients. Item KS (n [ 39) IHH (n [ 40) Before TRT After TRT Before TRT After TRT Age (y) Height (cm) a Weight (kg) b a b,c BMI (kg/m 2 ) b b,c Testes size (ml) FSH (U/L) b a LH (U/L) b a T (nmol/l) b b CHOL (mmol/l) TG (mmol/l) a b LDL-c (mmol/l) b HDL-c (mmol/l) FBG (mmol/l) Incidence of metabolic syndrome (%) a 20 Incidence of diabetes (%) c Note: CHOL ¼ cholesterol; TG ¼ triglyceride; LDL-c ¼ LDL-cholesterol; HDL-c ¼ HDL-cholesterol; FBG ¼ fasting blood glucose. a Compared with KS group before TRT, P<.05. b Compared with the same group before TRT, P<.05. c Compared with KS group after TRT, P<.05. Comorbidities. Among the diabetic patients, one had acute pancreatitis, and two had very high levels of triglyceride (Table 2). IHH Patients A total of 40 IHH patients participated in the study. No patients underwent puberty at the age of 18 years. Testosterone was administered for a median of 5.2 years, ranging from 2 to 32 years. Metabolic syndrome. The prevalence of metabolic syndrome was 15% before TRT. After TRT for a median of 5.2 years, the incidence of metabolic syndrome increased to 20%. FIGURE 1 In the Klinefelter patient group, BMI dramatically increased in nine patients during follow-up. Diabetes. The prevalence of diabetes was 5% (2 of 40). The diagnosis was made at the age of 47 and 52 years, respectively. Both had TRT for approximately 20 years before the diagnosis. Blood glucose was well controlled by metformin and glimepiride. Weight. During the follow-up, average body weight increase was kg. Comorbidities. No comorbidities were documented. DISCUSSION The aim of this study was to investigate the metabolic abnormalities in KS patients. The results showed that in KS patients the prevalence of metabolic syndrome increased from 30.8% to 38.5% during a median follow-up period of 4 years, and the incidence of diabetes was 20.5%, significantly higher than in IHH patients and the normal population. The diabetic KS patients had the following clinical features: [1] diabetes occurring at a relatively young age (approximately 30 years); [2] other risk factors for diabetes, such as acute pancreatitis and high triglyceride levels; [3] blood glucose could not be well controlled, even though insulin was administered; [4] incidence of diabetes was still high regardless of TRT; and [5] some patients had low BMI when the diagnosis of diabetes was made (Table 2). To the best of our knowledge, to date, this study has the largest sample size and the longest follow-up time. The mechanisms of diabetes in KS have not been well elucidated (2). Testosterone deficiency has been assumed to be the underlying mechanism (7,8). It is reported that insulin resistance and the incidence of diabetes increased in patients with prostate cancer who received T deprivation therapy (9). Several other epidemic studies have also revealed that the incidence of metabolic syndrome and type 2 diabetes increased in male populations with low levels of VOL. 98 NO. 5 / NOVEMBER
4 ORIGINAL ARTICLE: REPRODUCTIVE ENDOCRINOLOGY TABLE 2 Basic line data and clinical features in patients with KS and diabetes (n [ 8). Therapeutic regimens for diabetes Starting T therapy (y) Height (cm) Weight (kg) Karyotype HbA1c (%) Comorbidities Age at diagnosis of diabetes (y) Patient no. P xxy 6.6 Severe pancreatitis, fatty liver Lantus þ NovoRapid P xxy/46xx 10.4 Fatty liver Novomix 30 þ metformin P xxy 11.2 Severe fatty liver Metformin P xxxy 6.9 Mental retardation Refuse to take medicine P xy/47xxy 9.9 TG 32 mmol/l, fatty liver Novomix 30 P xy/47xxy 7.7 Acute myeloid leukemia M3 Refuse to take medicine P xxy 9.1 Fatty liver Metformin þ regular insulin P xxy 6.4 TG 11 mmol/l Metformin T (10 12). Indeed, TRT has been shown to improve metabolic status and insulin sensitivity (13,14). Our study showed that the incidence of diabetes is much higher in KS patients than in IHH patients, even though they were all androgen-deficient populations and received similar TRT. This suggests that T deficiency or replacement did not play a necessary role in the development of diabetes. In addition, body weight and BMI significantly increased during long-term TRT (Fig. 1). The cause-and-effect relationship between T and diabetes is thus still very controversial. Abdominal obesity and metabolic syndrome are significant risk factors for diabetes. One study has found that the incidence of abdominal obesity and metabolic syndrome in KS patients was 44%, much higher than the 10% in the control group (7). Even with the same BMI, visceral adipose and waist circumference was significantly higher in KS patients than in a control group (15). Using a hyperinsulinemia euglycemia clamp, the most sensitive assay for insulin sensitivity, Yesilova et al. (16) discovered that KS patients have significantly lower insulin sensitivity than a control group. Consistent with these studies, our data showed that the incidence of metabolic syndrome in KS patients was 30.8% at the beginning and then increased to 38.5% during the follow-up. Another possible mechanism for diabetes may involve the extra copies of X chromosomes. The genes, locating in additional X chromosomes, lead to seminiferous tubule hyaline degeneration by means of a gene dosage effect (17). We speculated that the similar gene dosage effect might cause insulin secretion deficiency, increased insulin resistance, or both, and contribute to diabetes. Indeed, we found that there was a close relationship between karyotypes and diabetes (Table 3): the incidence of diabetes was 12.5% in patients with a karyotype of 47,XXY, whereas it increased to 57.1% in patients with other karyotypes (P¼.08). The result is consistent with other studies showing that the incidence of diabetes was 5 of 24 (20.8%) in patients with 47,XXY karyotype, but 7 of 7 patients (100%) with other karyotypes (4 patients with 46,XY/47,XXY chimera and 3 patients with 49,XXXXY) (2). The data revealed a tendency that the more copies of X chromosome, the higher the risk for diabetes. Autoimmune disease may also be involved in the development of diabetes. Islet cell antibodies and glutamic acid decarboxylase antibodies can be detected in some patients with KS and diabetes (18). In addition, our study found some other diabetic risk factors in KS patients, such as acute pancreatitis, high triglyceride TABLE 3 Relationship between incidence of diabetes and karyotype. Karyotype No. of patients (diabetes/total patients) Incidence of diabetes mellitus (%) Classic karyotype (47,XXY) 4/ Atypical karyotype (46XY/47XXY 4/ a chimera and others) Total 8/ a P¼.008 compared with patients with classic karyotype 47,XXY VOL. 98 NO. 5 / NOVEMBER 2012
5 Fertility and Sterility level, fat liver, and increased BMI after androgen therapy. As we know, pancreatitis and hypertriglyceridemia is beyond the side effects of T therapy (19). All these factors could aggravate insulin resistance and impair b cell function. There are limitations to our study. First, the sample size of our study was relatively small, especially the number of diabetic KS patients. This may potentially affect the relationship estimates between KS and diabetes. However, this issue may, at least in part, be obviated by the fact that our data appear largely consistent with previous studies on this topic. Second, we did not perform multivariable logistic regression analysis to exclude the contribution of physical activity, food intake, socioeconomic status, and education to the development of diabetes after long-term TRT. Third, the study is retrospective and observational and is potentially susceptible to several forms of bias. To conclude, our study shows that the prevalence of diabetes is significantly increasing in KS patients compared with IHH patients, independent of TRT. The gene dosage effects from the additional X chromosomes are speculated to be the important mechanism for diabetes. Other risk factors, such as abdominal obesity, increased body weight, hypertriglyceridemia, and pancreatitis are also contributing. Lifelong management of these risk factors, especially increasing BMI during TRT, is necessary. REFERENCES 1. Bojesen A, Gravholt CH. Klinefelter syndrome in clinical practice. Nat Clin Pract Urol 2007;4: Nielsen J, Johansen K, Yde H. Frequency of diabetes mellitus in patients with Klinefelter's syndrome of different chromosome constitutions and the XYY syndrome. Plasma insulin and growth hormone level after a glucose load. J Clin Endocrinol Metab 1969;29: Robinson S, Kessling A. Diabetes secondary to genetic disorders. Baillieres Clin Endocrinol Metab 1992;6: Becker KL, Hoffman DL, Underdahl LO, Mason HL. Klinefelter's syndrome: clinical and laboratory findings in50 patients. Arch Intern Med 1966;118: Bojesen A, Juul S, Birkebaek NH, Gravholt CH. Morbidity in Klinefelter syndrome: a Danish register study based on hospital discharge diagnoses. J Clin Endocrinol Metab 2006;91: Alberti KG, Zimmet P, Shaw J. Metabolic syndrome a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006;23: Bojesen A, Kristensen K, Birkebaek NH, Fedder J, Mosekilde L, Bennett P, et al. The metabolic syndrome is frequent in Klinefelter's syndrome and is associated with abdominal obesity and hypogonadism. Diabetes Care 2006;29: Ota K, Suehiro T, Ikeda Y, Arii K, Kumon Y, Hashimoto K. Diabetes mellitus associated with Klinefelter's syndrome: a case report and review in Japan. Intern Med 2002;41: Saylor PJ, Smith MR. Metabolic complications of androgen deprivation therapy for prostate cancer. J Urol 2009;181: Kapoor D, Malkin CJ, Channer KS, Jones TH. Androgens, insulin resistance and vascular disease in men. Clin Endocrinol 2005;63: Laaksonen DE, Niskanen L, Punnonen K, Nyyssonen K, Tuomainen TP, Valkonen VP, et al. Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care 2004;27: Svartberg J, Jenssen T, Sundsfjord J, Jorde R. The associations of endogenous testosterone and sex hormone-binding globulin with glycosylated hemoglobin levels, in community dwelling men: the Tromso Study. Diabetes Metab 2004;30: Corona G, Monami M, Rastrelli G, Aversa A, Tishova Y, Saad F, et al. Testosterone and metabolic syndrome: a meta-analysis study. J Sex Med 2011;8: Jones TH, Arver S, Behre HM, Buvat J, Meuleman E, Moncada I, et al. Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 study). Diabetes Care 2011; 34: Bojesen A, Høst C, Gravholt CH. Klinefelter's syndrome, type 2 diabetes and the metabolic syndrome: the impact of body composition. Mol Hum Reprod 2010;16: Yesilova Z, Oktenli C, Sanisoglu SY, Musabak U, Cakir E, Ozata M, et al. Evaluation of insulin sensitivity in patients with Klinefelter's syndrome: a hyperinsulinemic euglycemic clamp study. Endocrine 2005;27: Barbaro M, Oscarson M, Schoumans J, Staaf J, Ivarsson SA, Wedell A. Isolated 46, XY gonadal dysgenesis in two sisters caused by a Xp21.2 interstitial duplication containing the DAX1 gene. J Clin Endocrinol Metab 2007;92: Pamuk BO, Torun AN, Kulaksizoglu M, Algan C, Ertugrul DT, Yilmaz Z, et al. 49, XXXXY syndrome with autoimmune diabetes and ocular manifestations. Med Princ Pract 2009;18: Kaufman JM, Miller MG, Garwin JL, Fitzpatrick S, McWhirter C, Brennan JJ. Efficacy and safety study of 1.62% testosterone gel for the treatment of hypogonadal men. J Sex Med 2011;8: VOL. 98 NO. 5 / NOVEMBER
Metabolic Effects of Androgen-associated Body Mass in Klinefelter Syndrome
Research Article imedpub Journals http://www.imedpub.com/ ARCHIVES OF MEDICINE DOI: 10.21767/1989-5216.1000257 Metabolic Effects of Androgen-associated Body Mass in Klinefelter Syndrome Ehrhart MD, Guthrie
More informationPrimary Hypogonadism In Ghanaian Men With Type 2 Diabetes Mellitus
Primary Hypogonadism In Ghanaian Men With Type 2 Diabetes Mellitus H. Asare-Anane, E.K. Ofori, F.A.Yeboah, E.A. Tagoe, S.B. Bani, A.T. Bawah, R.O Ateko Abstract-Emerging evidence links insulin resistance,
More informationChanges and clinical significance of serum vaspin levels in patients with type 2 diabetes
Changes and clinical significance of serum vaspin levels in patients with type 2 diabetes L. Yang*, S.J. Chen*, G.Y. Yuan, D. Wang and J.J. Chen Department of Endocrinology, Affiliated Hospital of Jiangsu
More informationIndex. urologic.theclinics.com. Note: Page numbers of article titles are in boldface type.
Note: Page numbers of article titles are in boldface type. A Acquired hypogonadism, prevalence of, 165 167 primary, 165 secondary, 167 Adipose tissue, as an organ, 240 241 Adrenal hyperplasia, congenital,
More informationMetabolic Syndrome.
www.bmiweightloss.com.au What is the metabolic syndrome? The was first described in 1988 by Gerald Reavson It was originally described as the clustering of four conditions These conditions when present
More information290 Biomed Environ Sci, 2016; 29(4):
290 Biomed Environ Sci, 2016; 29(4): 290-294 Letter to the Editor Prevalence and Predictors of Hypertension in the Labor Force Population in China: Results from a Cross-sectional Survey in Xinjiang Uygur
More informationPREVALENCE OF METABOLİC SYNDROME İN CHİLDREN AND ADOLESCENTS
PREVALENCE OF METABOLİC SYNDROME İN CHİLDREN AND ADOLESCENTS Mehmet Emre Atabek,MD,PhD Necmettin Erbakan University Faculty of Medicine, Department of Pediatrics, Division of Pediatric Endocrinology and
More informationMetabolic Syndrome Update The Metabolic Syndrome: Overview. Global Cardiometabolic Risk
Metabolic Syndrome Update 21 Marc Cornier, M.D. Associate Professor of Medicine Division of Endocrinology, Metabolism & Diabetes University of Colorado Denver Denver Health Medical Center The Metabolic
More informationfor months until the diagnosis were confirmed 86 were IHH and the other 47 were CDP. Repeated triptorelin stimulating tests were conducted in 9
ACTA ACADEMIAE MEDICINAE SINICAE 100730 010-65295073 wsheyan@vip.sina.com LHRH IHH CDP 133 IHH 86 CDP 47 14 24 ~ 48 9 IHH 13 CDP 1 - - LH LH IHH CDP IHH LH 1. 9 ± 1. 2 U /L CDP LH 13. 7 ± 8. 3 U /L P
More informationLetter to the Editor. Association of TCF7L2 and GCG Gene Variants with Insulin Secretion, Insulin Resistance, and Obesity in New-onset Diabetes *
814 Biomed Environ Sci, 2016; 29(11): 814-817 Letter to the Editor Association of TCF7L2 and GCG Gene Variants with Insulin Secretion, Insulin Resistance, and Obesity in New-onset Diabetes * ZHANG Lu 1,^,
More informationResearch Article Associated Factors with Biochemical Hypoglycemia during an Oral Glucose Tolerance Test in a Chinese Population
Hindawi Diabetes Research Volume 2017, Article ID 3212814, 5 pages https://doi.org/10.1155/2017/3212814 Research Article Associated Factors with Biochemical Hypoglycemia during an Oral Glucose Tolerance
More informationObjectives. Objectives. Alejandro J. de la Torre, MD Cook Children s Hospital May 30, 2015
Alejandro J. de la Torre, MD Cook Children s Hospital May 30, 2015 Presentation downloaded from http://ce.unthsc.edu Objectives Understand that the obesity epidemic is also affecting children and adolescents
More informationMetabolic Syndrome among Type-2 Diabetic Patients in Benghazi- Libya: A pilot study. Arab Medical University. Benghazi, Libya
Original Article Metabolic Syndrome among Type-2 Diabetic Patients in Benghazi- Libya: A pilot study Alshkri MM 1, Elmehdawi RR 2 1 Benghazi Diabetes Center. 2 Medical Department, Faculty of Medicine,
More informationThe Metabolic Syndrome Update The Metabolic Syndrome Update. Global Cardiometabolic Risk
The Metabolic Syndrome Update 2018 Marc Cornier, M.D. Professor of Medicine Division of Endocrinology, Metabolism & Diabetes Anschutz Health and Wellness Center University of Colorado School of Medicine
More informationSupplementary Online Content
Supplementary Online Content Larsen JR, Vedtofte L, Jakobsen MSL, et al. Effect of liraglutide treatment on prediabetes and overweight or obesity in clozapine- or olanzapine-treated patients with schizophrenia
More informationAssociation of serum adipose triglyceride lipase levels with obesity and diabetes
Association of serum adipose triglyceride lipase levels with obesity and diabetes L. Yang 1 *, S.J. Chen 1 *, G.Y. Yuan 1, L.B. Zhou 2, D. Wang 1, X.Z. Wang 1 and J.J. Chen 1 1 Department of Endocrinology,
More informationAssociation of hypothyroidism with metabolic syndrome - A case- control study
Article ID: ISSN 2046-1690 Association of hypothyroidism with metabolic syndrome - A case- control study Peer review status: No Corresponding Author: Dr. Veena K Karanth, Associate Professor, Surgery,
More informationRetrospective Study of Klinefelter Syndrome in Chinese Boys
HK J Paediatr (new series) 2010;15:111-115 Retrospective Study of Klinefelter Syndrome in Chinese Boys KM BELARAMANI, LM WONG, NS KWONG Abstract Key words Background: Klinefelter syndrome (KS) is a common
More informationStudy of the correlation between growth hormone deficiency and serum leptin, adiponectin, and visfatin levels in adults
Study of the correlation between growth hormone deficiency and serum leptin, adiponectin, and visfatin levels in adults Z.-P. Li 1, M. Zhang 2, J. Gao 3, G.-Y. Zhou 3, S.-Q. Li 1 and Z.-M. An 3 1 Golden
More informationInteresting Case Series. Gynecomastia and Klinefelter Syndrome
Interesting Case Series Gynecomastia and Klinefelter Syndrome Carol J. Singer-Granick, MD, a Tom Reisler, BSc(Hons), MBChB, MRCSEd, b and Mark Granick, MD b a Division of Pediatric Endocrinology, Department
More informationEAU GUIDELINES ON MALE HYPOGONADISM
EAU GUIDELINES ON MALE HYPOGONADISM (Limited text update March 2017) G.R. Dohle (Chair), S. Arver, C. Bettocchi, T.H. Jones, S. Kliesch Introduction Male hypogonadism is a clinical syndrome caused by androgen
More informationCytogenetic Studies in Indian Population suspected to have Klinefelter syndrome
Journal of Advanced Research in Biology Volume 1, Issue 1&2-2018, Pg. No. 21-25 Peer Reviewed Journal Research Article Cytogenetic Studies in Indian Population suspected to have Klinefelter syndrome Shailesh
More informationObesity and Insulin Resistance According to Age in Newly Diagnosed Type 2 Diabetes Patients in Korea
https://doi.org/10.7180/kmj.2016.31.2.157 KMJ Original Article Obesity and Insulin Resistance According to Age in Newly Diagnosed Type 2 Diabetes Patients in Korea Ju Won Lee, Nam Kyu Kim, Hyun Joon Park,
More informationMetabolic Syndrome. Shon Meek MD, PhD Mayo Clinic Florida Endocrinology
Metabolic Syndrome Shon Meek MD, PhD Mayo Clinic Florida Endocrinology Disclosure No conflict of interest No financial disclosure Does This Patient Have Metabolic Syndrome? 1. Yes 2. No Does This Patient
More informationJournal of the American College of Cardiology Vol. 48, No. 2, by the American College of Cardiology Foundation ISSN /06/$32.
Journal of the American College of Cardiology Vol. 48, No. 2, 2006 2006 by the American College of Cardiology Foundation ISSN 0735-1097/06/$32.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2006.03.043
More informationAssociations among Body Mass Index, Insulin Resistance, and Pancreatic ß-Cell Function in Korean Patients with New- Onset Type 2 Diabetes
ORIGINAL ARTICLE korean j intern med 2012;27:66-71 pissn 1226-3303 eissn 2005-6648 Associations among Body Mass Index, Insulin Resistance, and Pancreatic ß-Cell Function in Korean Patients with New- Onset
More informationLaboratory analysis of the obese child recommendations and discussion. MacKenzi Hillard May 4, 2011
Laboratory analysis of the obese child recommendations and discussion MacKenzi Hillard May 4, 2011 aka: What to do with Fasting Labs The Obesity Epidemic The prevalence of obesity in adolescents has tripled
More informationTestosterone therapy (TTh) prevents progression from prediabetes to type 2 diabetes (T2DM) in hypogonadal: 9-year data from a registry study
Testosterone therapy (TTh) prevents progression from prediabetes to type 2 diabetes (T2DM) in hypogonadal: 9-year data from a registry study F Saad 1,2, KS Haider 3, A Haider 3 1 Global Medical Affairs
More informationORIGINAL INVESTIGATION. C-Reactive Protein Concentration and Incident Hypertension in Young Adults
ORIGINAL INVESTIGATION C-Reactive Protein Concentration and Incident Hypertension in Young Adults The CARDIA Study Susan G. Lakoski, MD, MS; David M. Herrington, MD, MHS; David M. Siscovick, MD, MPH; Stephen
More informationGUIDELINES ON. Introduction. G.R. Dohle, S. Arver, C. Bettocchi, S. Kliesch, M. Punab, W. de Ronde
GUIDELINES ON Male Hypogonadism G.R. Dohle, S. Arver,. Bettocchi, S. Kliesch, M. Punab, W. de Ronde Introduction Male hypogonadism is a clinical syndrome caused by androgen deficiency. It may adversely
More informationLate onset hypogonadism
Late onset hypogonadism Farrukh Javid Male Menopause Clinical AND biochemical syndrome Testosterone levels decline by 0.4-3% per year after the age of 30, as opposed to the more rapid decline that occurs
More informationMETABOLIC SYNDROME IN OBESE CHILDREN AND ADOLESCENTS
Rev. Med. Chir. Soc. Med. Nat., Iaşi 2012 vol. 116, no. 4 INTERNAL MEDICINE - PEDIATRICS ORIGINAL PAPERS METABOLIC SYNDROME IN OBESE CHILDREN AND ADOLESCENTS Ana-Maria Pelin 1, Silvia Mǎtǎsaru 2 University
More informationDiabetes, Diet and SMI: How can we make a difference?
Diabetes, Diet and SMI: How can we make a difference? Dr. Adrian Heald Consultant in Endocrinology and Diabetes Leighton Hospital, Crewe and Macclesfield Research Fellow, Manchester University Relative
More informationAntim ullerian hormone and polycystic ovary syndrome
Antim ullerian hormone and polycystic ovary syndrome Yi-Hui Lin, M.D., a Wan-Chun Chiu, Ph.D., c Chien-Hua Wu, Ph.D., b,e Chii-Ruey Tzeng, M.D., d Chun-Sen Hsu, M.D., a and Ming-I Hsu, M.D. a a Department
More informationThe investigation of serum lipids and prevalence of dyslipidemia in urban adult population of Warangal district, Andhra Pradesh, India
eissn: 09748369, www.biolmedonline.com The investigation of serum lipids and prevalence of dyslipidemia in urban adult population of Warangal district, Andhra Pradesh, India M Estari, AS Reddy, T Bikshapathi,
More informationEffective Interventions in the Clinical Setting: Engaging and Empowering Patients. Michael J. Bloch, M.D. Doina Kulick, M.D.
Effective Interventions in the Clinical Setting: Engaging and Empowering Patients Michael J. Bloch, M.D. Doina Kulick, M.D. UNIVERSITY OF NEVADA SCHOOL of MEDICINE Sept. 8, 2011 Reality check: What could
More informationSerum Retinol-binding Protein 4 Levels in Patients with Diabetic Retinopathy
The Journal of International Medical Research 2010; 38: 95 99 Serum Retinol-binding Protein 4 Levels in Patients with Diabetic Retinopathy Z-Z LI 1, X-Z LU 2, J-B LIU 1 AND L CHEN 1 1 Department of Endocrinology,
More informationLower levels sex hormone-binding globulin independently associated with metabolic syndrome in pre-elderly and elderly men in China
Journal of Geriatric Cardiology (2013) 10: 28 33 2013 JGC All rights reserved; www.jgc301.com Research Article Open Access Lower levels sex hormone-binding globulin independently associated with metabolic
More informationElevated Serum Levels of Adropin in Patients with Type 2 Diabetes Mellitus and its Association with
Elevated Serum Levels of Adropin in Patients with Type 2 Diabetes Mellitus and its Association with Insulin Resistance Mehrnoosh Shanaki, Ph.D. Assistant Professor of Clinical Biochemistry Shahid Beheshti
More informationRecommendations on the diagnosis, treatment and monitoring of Testosterone deficiency (TD) in adult men
Recommendations on the diagnosis, treatment and monitoring of Testosterone deficiency (TD) in adult men Bruno Lunenfeld, George Mskhalaya, Svetlana Kalinchenko, Yulia Tishova, Michael Zitzmann, Stefan
More informationMetabolic syndrome and insulin resistance in an urban and rural adult population in Sri Lanka
Original Metabolic paper syndrome and insulin resistance in an urban and rural adult population in Sri Lanka Metabolic syndrome and insulin resistance in an urban and rural adult population in Sri Lanka
More information3/20/2011. Body Mass Index (kg/[m 2 ]) Age at Issue (*BMI > 30, or ~ 30 lbs overweight for 5 4 woman) Mokdad A.H.
U.S. Adults: 1988 Nineteen states with 10-14% 14% Prevalence of Obesity (*BMI > 30, or ~ 30 lbs overweight for 5 4 woman) Metabolic John P. Cello, MD Professor of Medicine and Surgery, University of California,
More informationSerum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic
Supplementary Information The title of the manuscript Serum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic stroke Xin-Wei He 1, Wei-Ling Li 1, Cai Li
More informationClinical Study Synopsis
Clinical Study Synopsis This Clinical Study Synopsis is provided for patients and healthcare professionals to increase the transparency of Bayer's clinical research. This document is not intended to replace
More informationMETABOLIC SYNDROME IN REPRODUCTIVE FEMALES
METABOLIC SYNDROME IN REPRODUCTIVE FEMALES John J. Orris, D.O., M.B.A Division Head, Reproductive Endocrinology & Infertility, Main Line Health System Associate Professor, Drexel University College of
More informationObesity in the pathogenesis of chronic disease
Portoroz October 16th 2013 Obesity in the pathogenesis of chronic disease Rocco Barazzoni University of Trieste Department of Medical, Surgical and Health Sciences Obesity Trends* Among U.S. Adults BRFSS,
More informationOriginal Article Effect of obesity and hyperglycemia on benign prostatic hyperplasia in elderly patients with newly diagnosed type 2 diabetes
Int J Clin Exp Med 2015;8(7):11289-11294 www.ijcem.com /ISSN:1940-5901/IJCEM0007877 Original Article Effect of obesity and hyperglycemia on benign prostatic hyperplasia in elderly patients with newly diagnosed
More informationReproductive Health in Non Alcoolic Fatty Liver Disease (NAFLD)
Reproductive Health in Non Alcoolic Fatty Liver Disease (NAFLD) Pr Sophie Christin-Maitre Reproductive Endocrine Unit, Hôpital Saint-Antoine, AP-HP Université Pierre et Marie Curie INSERM U933 Paris, France
More informationTestosterone Therapy in Men An update
Testosterone Therapy in Men An update SANDEEP DHINDSA Associate Professor of Medicine Director, Division of Endocrinology and Metabolism, Saint Louis University, St. Louis, MO Presenter Disclosure None
More informationDiabetes and Cardiovascular Risks in the Polycystic Ovary Syndrome
Diabetes and Cardiovascular Risks in the Polycystic Ovary Syndrome John E. Nestler, M.D. William Branch Porter Professor of Medicine Chair, Department of Internal Medicine Virginia Commonwealth University
More informationRELATIONSHIP OF CLINICAL FACTORS WITH ADIPONECTIN AND LEPTIN IN CHILDREN WITH NEWLY DIAGNOSED TYPE 1 DIABETES. Yuan Gu
RELATIONSHIP OF CLINICAL FACTORS WITH ADIPONECTIN AND LEPTIN IN CHILDREN WITH NEWLY DIAGNOSED TYPE 1 DIABETES by Yuan Gu BE, Nanjing Institute of Technology, China, 2006 ME, University of Shanghai for
More information902 Biomed Environ Sci, 2014; 27(11):
902 Biomed Environ Sci, 2014; 27(11): 902-906 Letter to the Editor Curcuminoids Target Decreasing Serum Adipocyte-fatty Acid Binding Protein Levels in Their Glucose-lowering Effect in Patients with Type
More informationMarshall Tulloch-Reid, MD, MPhil, DSc, FACE Epidemiology Research Unit Tropical Medicine Research Institute The University of the West Indies, Mona,
Marshall Tulloch-Reid, MD, MPhil, DSc, FACE Epidemiology Research Unit Tropical Medicine Research Institute The University of the West Indies, Mona, Jamaica At the end of this presentation the participant
More informationFigure S1. Comparison of fasting plasma lipoprotein levels between males (n=108) and females (n=130). Box plots represent the quartiles distribution
Figure S1. Comparison of fasting plasma lipoprotein levels between males (n=108) and females (n=130). Box plots represent the quartiles distribution of A: total cholesterol (TC); B: low-density lipoprotein
More informationThe Metabolic Syndrome Update The Metabolic Syndrome: Overview. Global Cardiometabolic Risk
Update 2013 Marc Cornier, M.D. Associate Professor of Medicine Division of Endocrinology, Metabolism & Diabetes Anschutz Health and Wellness Center University of Colorado School of Medicine Denver Health
More information300 Biomed Environ Sci, 2018; 31(4):
300 Biomed Environ Sci, 2018; 31(4): 300-305 Letter to the Editor Combined Influence of Insulin Resistance and Inflammatory Biomarkers on Type 2 Diabetes: A Population-based Prospective Cohort Study of
More informationSCIENTIFIC STUDY REPORT
PAGE 1 18-NOV-2016 SCIENTIFIC STUDY REPORT Study Title: Real-Life Effectiveness and Care Patterns of Diabetes Management The RECAP-DM Study 1 EXECUTIVE SUMMARY Introduction: Despite the well-established
More informationRelationship between cardiovascular risk factors and traditional Chinese constitution in subjects with high-normal blood pressure
World Journal of Cardiovascular Diseases, 2013, 3, 234-238 http://dx.doi.org/10.4236/wjcd.2013.32036 Published Online April 2013 (http://www.scirp.org/journal/wjcd/) WJCD Relationship between cardiovascular
More informationDiabetes mellitus. Treatment
Diabetes mellitus Treatment Recommended glycemic targets for the clinical management of diabetes(ada) Fasting glycemia: 80-110 mg/dl Postprandial : 100-145 mg/dl HbA1c: < 6,5 % Total cholesterol: < 200
More informationEAU GUIDELINES ON MALE HYPOGONADISM
EAU GUIDELINES ON MALE HYPOGONADISM (Text update March 2015) G.R. Dohle (Chair), S. Arver, C. Bettocchi, T.H. Jones, S. Kliesch, M. Punab Introduction Male hypogonadism is a clinical syndrome caused by
More informationUnraveling the concealed and calculated cardiovascular risks in diabetes
15 P B Fernando Memorial Oration 2015 Unraveling the concealed and calculated cardiovascular risks in diabetes Weerarathna T P 1 Journal of the Ceylon College of Physicians, 2016, 47, 15-19 Abstract Cardiovascular
More informationTesamorelin Clinical Data Overview Jean-Claude Mamputu, PhD Senior Medical Advisor, Theratechnologies
Tesamorelin Clinical Data Overview Jean-Claude Mamputu, PhD Senior Medical Advisor, Theratechnologies Copyright 2016. All Rights Reserved. Property of Theratechnologies Inc. Mechanism of Action of Tesamorelin
More informationPredictive value of overweight in early detection of metabolic syndrome in schoolchildren
Predictive value of overweight in early detection of metabolic syndrome in schoolchildren Marjeta Majer, Vera Musil, Vesna Jureša, Sanja Musić Milanović, Saša Missoni University of Zagreb, School of Medicine,
More informationTable S1. Characteristics associated with frequency of nut consumption (full entire sample; Nn=4,416).
Table S1. Characteristics associated with frequency of nut (full entire sample; Nn=4,416). Daily nut Nn= 212 Weekly nut Nn= 487 Monthly nut Nn= 1,276 Infrequent or never nut Nn= 2,441 Sex; n (%) men 52
More informationAssociation between Raised Blood Pressure and Dysglycemia in Hong Kong Chinese
Diabetes Care Publish Ahead of Print, published online June 12, 2008 Raised Blood Pressure and Dysglycemia Association between Raised Blood Pressure and Dysglycemia in Hong Kong Chinese Bernard My Cheung,
More informationHypogonadism 4/27/2018. Male Hypogonadism -- Definition. Epidemiology. Objectives HYPOGONADISM. Men with Hypogonadism. 95% untreated.
Male Hypogonadism -- Definition - Low T, Low Testosterone Hypogonadism -...a clinical syndrome that results from failure of the testes to produce physiological concentrations of testosterone due to pathology
More informationHypertriglyceridemia and the Related Factors in Middle-aged Adults in Taiwan
1 Hypertriglyceridemia and the Related Factors in Middle-aged Adults in Taiwan Cheng-Chieh Lin, Tsai-Chung Li 2, Shih-Wei Lai, Kim-Choy Ng 1, Kuo-Che Wang, Chiu-Shong Liu Department of Community Medicine,
More informationBlood Pressure Measurement (children> 3 yrs)
Blood Pressure Measurement (children> 3 yrs) If initial BP elevated, repeat BP manually 2x and average, then classify Normal BP Systolic and diastolic
More informationResearch Article Association of Insulin Resistance with Glucose and Lipid Metabolism: Ethnic Heterogeneity in Far Western China
Mediators of Inflammation Volume 2016, Article ID 3825037, 8 pages http://dx.doi.org/10.1155/2016/3825037 Research Article Association of Insulin Resistance with Glucose and Lipid Metabolism: Ethnic Heterogeneity
More informationCardiometabolic Side Effects of Risperidone in Children with Autism
Cardiometabolic Side Effects of Risperidone in Children with Autism Susan J. Boorin, MSN, PMHNP-BC PhD Candidate Yale School of Nursing 1 This speaker has no conflicts of interest to disclose. 2 Boorin
More informationChromosomal Abnormalities and Karyotypes Creating a Karyotype
Chromosomal Abnormalities and Karyotypes Creating a Karyotype The Normal Human Karyotype The normal human karyotype is composed of SEVEN groups of chromosomes A G plus the sex chromosomes X and Y. The
More informationInfluence of testosterone replacement therapy on metabolic disorders in male patients with type 2 diabetes mellitus and androgen deficiency
Janjgava et al. European Journal of Medical Research 2014, 19:56 EUROPEAN JOURNAL OF MEDICAL RESEARCH RESEARCH Open Access Influence of testosterone replacement therapy on metabolic disorders in male patients
More informationInvestigators, study sites Multicenter, 35 US sites. Coordinating Investigator: Richard Bergenstal, MD
STUDY SYNOPSIS Study number Title HMR1964A/3502 Apidra (insulin glulisine) administered in a fixed-bolus regimen vs. variable-bolus regimen based on carbohydrate counting in adult subjects with type 2
More informationRelationship of Waist Circumference and Lipid Profile in Children
International Journal of Biomedical Science and Engineering 2015; 3(3): 44-48 Published online May 28, 2015 (http://www.sciencepublishinggroup.com/j/ijbse) doi: 10.11648/j.ijbse.20150303.12 ISSN: 2376-7227
More informationWEIGHT CHANGE AND ANDROGEN LEVELS DURING CONTRACEPTIVE TREATMENT OF WOMEN AFFECTED BY POLYCYSTIC OVARY
ENDOCRINE REGULATIONS, VOL. 40, 119-123, 2006 119 WEIGHT CHANGE AND ANDROGEN LEVELS DURING CONTRACEPTIVE TREATMENT OF WOMEN AFFECTED BY POLYCYSTIC OVARY J. VRBIKOVA, K. DVORAKOVA, M. HILL, L. STARKA Institute
More informationZhengtao Liu 1,2,3*, Shuping Que 4*, Lin Zhou 1,2,3 Author affiliation:
Dose-response Relationship of Serum Uric Acid with Metabolic Syndrome and Non-alcoholic Fatty Liver Disease Incidence: AMeta-analysis of Prospective Studies Zhengtao Liu 1,2,3*, Shuping Que 4*, Lin Zhou
More informationDifference in glucagon-like peptide-1 concentrations between C-peptide negative type 1 diabetes mellitus patients and healthy controls
Original Article Annals of Clinical Biochemistry 2015, Vol. 52(2) 220 225! The Author(s) 2014 Reprints and permissions: sagepub.co.uk/journalspermissions.nav DOI: 10.1177/0004563214544709 acb.sagepub.com
More informationINSULIN RESISTANCE, POLYCYSTIC OVARIAN SYNDROME An Overview
INSULIN RESISTANCE, POLYCYSTIC OVARIAN SYNDROME An Overview University of PNG School of Medicine & Health Sciences Division of Basic Medical Sciences PBL MBBS III VJ Temple 1 Insulin Resistance: What is
More informationCardiovascular Risk Factors among Diabetic Patients Attending a Nigerian Teaching Hospital. O Alao, S Adebisi, G Jombo, D Joseph, O Damulak, F Puepet
ISPUB.COM The Internet Journal of Endocrinology Volume 6 Number 1 Cardiovascular Risk Factors among Diabetic Patients Attending a Nigerian Teaching Hospital. O Alao, S Adebisi, G Jombo, D Joseph, O Damulak,
More informationGonadal Dysfunction with Postprandial Hypertriglyceridemia is Risk Predictor of Cardiovascular Disease in Men with Type 2 Diabetes Mellitus
Iraqi JMS Published by Al-Nahrain College of Medicine ISSN 1681-6579 Email: iraqijms@colmed-alnahrain.edu.iq http://www.colmed-nahrain.edu.iq Gonadal Dysfunction with Postprandial Hypertriglyceridemia
More informationObesity and Testosterone Levels in Ghanaian Men With Type 2 Diabetes
Obesity and Testosterone Levels in Ghanaian Men With Type 2 Diabetes Henry Asare-Anane, PhD, Emmanuel Ofori, MPhil, Yeboah Agyemang, PhD, Sylvester Oppong, MBChB, PhD, Emmanuel Tagoe, MPhil, Simon Bani,
More informationPrevalence of Comorbidities among HIV-positive patients in Taiwan
Prevalence of Comorbidities among HIV-positive patients in Taiwan Chien-Ching Hung, MD, PhD Department of Internal Medicine National Taiwan University Hospital, Taipei, Taiwan % of participants Comorbidity
More informationProf. Dr. Michael Zitzmann Internal Medicine Endocrinology, Diabetology, Andrology University of Muenster, Germany
Induction of fertility in hypogonadal men Prof. Dr. Michael Zitzmann Internal Medicine Endocrinology, Diabetology, Andrology University of Muenster, Germany Induction of fertility in hypogonadal men Prof.
More informationDiagnosis and Clinical Evaluation of Hypogonadism in Adult Patients with Obesity and Diabetes
Diagnosis and Clinical Evaluation of Hypogonadism in Adult Patients with Obesity and Diabetes Adrian Dobs, M.D., M.H.S. Professor of Medicine and Oncology The Johns Hopkins University School of Medicine
More informationTreating Type 2 Diabetes by Treating Obesity. Vijaya Surampudi, MD, MS Assistant Professor of Medicine Center for Human Nutrition
Treating Type 2 Diabetes by Treating Obesity Vijaya Surampudi, MD, MS Assistant Professor of Medicine Center for Human Nutrition 2 Center Stage Obesity is currently an epidemic in the United States, with
More informationROLE OF HORMONAL ASSAY IN DIAGNOSING PCOD DR GAANA SREENIVAS (JSS,MYSURU)
ROLE OF HORMONAL ASSAY IN DIAGNOSING PCOD DR GAANA SREENIVAS (JSS,MYSURU) In 1935, Stein and Leventhal described 7 women with bilateral enlarged PCO, amenorrhea or irregular menses, infertility and masculinizing
More informationThe clinical importance of testosterone in men with type 2 diabetes
22 The clinical importance of testosterone in men with type 2 diabetes GEOFF HACKETT Although the association of low testosterone with type 2 diabetes is well established, testosterone levels are not routinely
More informationClinical surrogate markers for predicting metabolic syndrome in middle-aged and elderly Chinese
Clinical surrogate markers for predicting metabolic syndrome in middle-aged and elderly Chinese Rui Li 1,QiLi 1, Min Cui 2,ZegangYin 2,LingLi 2, Tingting Zhong 2, Yingchao Huo 2, Peng Xie 1,3 * 1 Department
More informationyear resident, Department of Medicine, B. J. Medical college, Ahmedabad.
Clinical Study of Type 2 Diabetes Mellitus Patients with or without Cerebrovascular Feature and Its Correlation with Other Comorbidity / Diabetic Complication Vivek Sidhapura 1*, Bipin Amin 2, Amit Potulwar
More informationMETABOLIC RISK MARKERS IN WOMEN WITH POLYCYSTIC OVARIAN MORPHOLOGY
Vuk Vrhovac University Clinic Dugi dol 4a, HR-10000 Zagreb, Croatia Original Research Article Received: February 18, 2010 Accepted: March 3, 2010 METABOLIC RISK MARKERS IN WOMEN WITH POLYCYSTIC OVARIAN
More informationPromotive effect of comprehensive management on achieving blood glucose control in senile type 2 diabetics
Promotive effect of comprehensive management on achieving blood glucose control in senile type 2 diabetics S.-T. Yan, C.-X. Li, C.-L. Li, J. Li, Y.-H. Shao, Y. Liu, W.-W. Zhong, F.-S. Fang, B.-R. Sun and
More informationImpact of Physical Activity on Metabolic Change in Type 2 Diabetes Mellitus Patients
2012 International Conference on Life Science and Engineering IPCBEE vol.45 (2012) (2012) IACSIT Press, Singapore DOI: 10.7763/IPCBEE. 2012. V45. 14 Impact of Physical Activity on Metabolic Change in Type
More informationMALE INFERTILITY & SEMEN ANALYSIS
MALE INFERTILITY & SEMEN ANALYSIS DISCLOSURE Relevant relationships with commercial entities none Potential for conflicts of interest within this presentation none Steps taken to review and mitigate potential
More informationGUIDELINES ON MALE HYPOGONADISM
GUIDELINES ON MALE HYPOGONADISM (Text update March 2015) G.R. Dohle (Chair), S. Arver, C. Bettocchi, T.H. Jones, S. Kliesch, M. Punab Introduction Male hypogonadism is a clinical syndrome caused by androgen
More informationCardiovascular Complications of Diabetes
VBWG Cardiovascular Complications of Diabetes Nicola Abate, M.D., F.N.L.A. Professor and Chief Division of Endocrinology and Metabolism The University of Texas Medical Branch Galveston, Texas Coronary
More informationAssociation between metabolic syndrome and its components with presbycusis
538 44 4 2015 7 JOURNAL OF HYGIENE RESEARCH Vol. 44 No. 4 Jul. 2015 1000-8020 2015 04-0538-06 檾檾檾檾 DANONE INSTITUTE CHINA Young Scientists' Forum 檾檾檾檾檾檾檾檾檾檾檾檾檾檾檾檾檾檾檾檾檾檾檾檾檾檾檾檾 1 150081 1 2013 6-2014 8 165
More informationDIAGNOSED ADULTS FOR RESEARCH: Running title: Disclosing a prenatal diagnosis. Amy S Herlihy, Jane L Halliday, Lynn H Gillam
ETHICAL ISSUES IN RECRUITING PRENATALLY DIAGNOSED ADULTS FOR RESEARCH: KLINEFELTER SYNDROME AS AN EXAMPLE [SHORT COMMUNICATION] Running title: Disclosing a prenatal diagnosis Amy S Herlihy, Jane L Halliday,
More informationMetabolic Syndrome: What s in a name?
Commentary Metabolic Syndrome: What s in a name? Deborah P. Wubben, MD, MPH; Alexandra K. Adams, MD, PhD Abstract The term metabolic syndrome has recently become en vogue. But is the definition realistic,
More informationMetabolic syndrome in females with polycystic ovary syndrome and International Diabetes Federation criteria
doi:10.1111/j.1447-0756.2007.00685.x J. Obstet. Gynaecol. Res. Vol. 34, No. 1: 62 66, February 2008 Metabolic syndrome in females with polycystic ovary syndrome and International Diabetes Federation criteria
More informationTotal risk management of Cardiovascular diseases Nobuhiro Yamada
Nobuhiro Yamada The worldwide burden of cardiovascular diseases (WHO) To prevent cardiovascular diseases Beyond LDL Multiple risk factors With common molecular basis The Current Burden of CVD CVD is responsible
More information